Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals
复制标题
DOI：
10.4251/wjgo.v8.i2.165
复制
发表时间：
2016-02-15
影响因子：
3
通讯作者：
Yang, Min
中科院分区：
文献类型：
--
作者：
Xu, Yu-Ping;Yang, Min
胰腺癌（PC）是一个严重的健康问题。传统的成像方式显示有限的准确性，可靠的评估肿瘤。近年来的研究表明，示踪分子成像技术能提供更多的生物学相关信息，有助于肿瘤的诊断。此外，放射性药物在疾病的治疗中也发挥着越来越重要的作用。本文综述了放射性标记化合物在前列腺癌诊断治疗中的研究进展。
Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.